<?xml version="1.0" encoding="UTF-8"?>
<ref id="b12-1040797">
 <label>12.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Michallet</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Aktan</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Hiddemann</surname>
    <given-names>W</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study</article-title>. 
  <source>Haematologica</source>. 
  <year>2018</year>;
  <volume>103</volume>(
  <issue>4</issue>):
  <fpage>698</fpage>â€“
  <lpage>706</lpage>.
  <pub-id pub-id-type="pmid">29419437</pub-id>
 </mixed-citation>
</ref>
